Zai Lab (NASDAQ:ZLAB) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.06) by 666.67 percent. This is a 24.32 percent decrease over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $105.751 million which beat the analyst consensus estimate of $105.323 million by 0.41 percent. This is a 3.84 percent decrease over sales of $109.977 million the same period last year.